| Literature DB >> 33343036 |
Desiree S Machado1, Manjiri Tule1, Joseph Philip1, Tung Wynn1, Michael Lazarowicz1, Tiago Machuca1, Mauricio Pipkin1, Hassan Alnuhaimat1, Mohammad Ebraheem1, Giles Peek1, Mark Bleiweis1.
Abstract
Saddle pulmonary embolism (PE) remains a challenge to diagnose and manage in pediatric patients. Current literature encourages early consideration of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in high-risk PE patients with impending right ventricular failure. We present a 17-year-old patient who was admitted to a pediatric cardiac intensive care unit with saddle PE requiring emergent VA-ECMO support because of cardiovascular collapse. Despite anticoagulation with bivalirudin and receiving systemic thrombolysis with alteplase, the clot burden was persistent with minimal improvement in right ventricular function. We proceeded to catheter thrombolysis while on VA-ECMO. This ultimately led to a successful resolution of the PE and allowed for weaning off VA-ECMO. PE is rare in children compared with adults, and pediatricians may be unaware of therapies becoming increasingly used in adults such as the use of VA-ECMO, with systemic and local thrombolysis. The concurrent use of a direct thrombin inhibitor for ECMO anticoagulation alongside the thrombolysis is a novel combination in this condition and age-group. © Copyright 2020 AMSECT.Entities:
Keywords: alteplase; anticoagulation; bivalirudin; children; direct thrombin inhibitor; pediatric; pulmonary embolism; thrombolysis; veno-arterial extracorporeal membrane oxygenation
Mesh:
Substances:
Year: 2020 PMID: 33343036 PMCID: PMC7728497 DOI: 10.1182/ject-2000013
Source DB: PubMed Journal: J Extra Corpor Technol ISSN: 0022-1058